253 Senate Russell Office Building

WASHINGTON, D.C. - U.S. Sen. Ted Cruz (R-Tex.), chairman of the Subcommittee on Space, Science, and Competitiveness, will hold a hearing entitled “Unlocking the Cures for America’s Most Deadly Diseases” on Tuesday, July 14, 2015, at 10:00 a.m.
 
The hearing will focus on incentivizing cure development for the most deadly diseases. In recent years, U.S. biomedical research and innovation has been lagging. According to a study published by the New England Journal of Medicine, the U.S. share of global biomedical research and development expenditures declined from 51 percent to 45 percent from 2007-2012. U.S. public sector spending was still the top in the world, but private sector biomedical research and development expenditures declined by almost $13 billion. Witnesses will provide testimony on how to encourage new private investment in biomedical research while also examining the government’s regulatory roadblocks that can hinder private investment.

Witnesses:
 
•    Dr. Tom Coburn, Former United States Senator (R-Okla.)

•    Mr. Christopher Frangione, Vice President, Prize Development, XPRIZE

•    Mr. Peter Huber, Senior Fellow, Manhattan Institute

•    Dr. Keith Yamamoto, Vice Chancellor for Research, University of California, San Francisco
 
Hearing Details:
 
Tuesday, July 14, 2015
 
10:00 a.m.
 
Subcommittee on Space, Science, and Competitiveness
 
Senate Russell Office Building, Room 253
 
Witness testimony, opening statements, and a live video of the hearing will be available on this page.

For reporters interested in reserving a seat, please contact the press gallery:

• Periodical Press Gallery – 202-224-0265

• Radio/Television Gallery – 202-224-6421

• Press Photographers Gallery – 202-224-6548

• Daily Press Gallery – 202-224-0241

Individuals with disabilities who require an auxiliary aid or service, including closed captioning service for the webcast hearing, should contact Stephanie Gamache at 202-224-5511 at least three business days in advance of the hearing date.